BIOM PHARMA

Biom Pharma | Biom Probiotics Sarasota | Human Microflora Probiotics

BIOM PHARMACEUTICAL CORPORATION

Biom Pharma is dedicated to achieving one of the most ambitious goals of 21st century medicine: increasing human longevity with high quality of life. This objective is at the heart of everything we do, from early research and development to product development. With this goal in mind we are focusing on developing true-to-label nutritional supplements to novel microbiome services to developing therapeutic modalities against hard-to-treat diseases.

To bring about this transformation, we are developing innovative designer drug products that harness a patient’s own microbiome to target various disease and pathological conditions.

Our innovative team of scientists, business leaders and engineers are focused on developing clinical-based microbiome technologies and services to address various metabolic and immune diseases. The company has developed several cutting-edge technologies for healthcare and consumer care market applications.

VISION

Be a global leader in developing microbiome-based drug technologies for safer, healthier and longer life for all.

MISSION

Drive a new generation of innovative drug products and technologies

CORE VALUES

  • Commitment & fun in driving innovation
  • Respect & reward for ‘out-of-the box’ creativity
  • Excellence in team work & performance
  • Social & environmental responsibility
  • Products oriented for safe and healthy human life
Biom Pharma | Biom Probiotics Sarasota | Human Microflora Probiotics

CORE COMPETANCIES

We will procure and build additional portfolio of patents, trademarks, and trade secrets to reinforce and protect our technologies. The core competencies of Biom Pharma include novel products and technologies, exceptional research, researchers, technologists and business team who will launch innovative products in developed and emerging markets in a fast-track way.

TECHNOLOGIES & IP RIGHTS

Biom Pharma has developed for four world-wide novel utility patents for protecting our microbiome-based novel products and services. We will procure and build additional portfolio of patents, trademarks, and trade secrets to reinforce and protect our technologies. Biom Pharma has developed for four world-wide novel utility patents for protecting our microbiome-based novel products and services

MANAGEMENT TEAM

  • Dr. Bobban Subhadra, President & Chief Executive Officer
  • Ulrich Elben, Chief Technology Officer
  • Greg Herbert, VP of Operations
  • Dennis Wonn, VP of Marketing
  • Vijitha Vivekanandan, Founder & VP of Accounting
  • Jenny Wilkins, NMD, Chief Medical Director (Alternative Medicine)

SCIENTIFIC ADVISORY TEAM

  • Dr. Nicholas Seeds, Professor Emeritus, School of Medicine, University of Colorado
  • Dr. Hitendra Chand, Associate Professor, School of Medicine, Florida International University, Florida
  • Dr. Gopi-Marakoosham, School of Medicine, University of New Mexico
  • Peter Simonson, President, Juvent Regenerative Corporation, FL
  • Arthur J Hodge, M.D. Internal Medicine and preventative care specialist

OUR TECHNOLOGIES

Biom Pharma | Biom Probiotics Sarasota | Human Microflora Probiotics | Longevity Enhancing Microbiome

Biom Designer Microbiome

We are developing Longevity-Enhancing Designer Microbiome. Our blue-zone microbiome project delineate longevity Enhancing microbiome.

Biom Pharma | Biom Probiotics Sarasota | Human Microflora Probiotics | Longevity Enhancing Microbiome

MDC Complex

Microbiome Diversifying Complex(MDC) expands microbiome metabolic potential by modulating gene expression and producing longevity-enhancing metabolites.

Biom Pharma | Biom Probiotics Sarasota | Human Microflora Probiotics | Longevity Enhancing Microbiome

BiomSafe

Our microbiome cataloguing and storing service. We study and track your Healthy microbiome when You are in the prime of your health so that you can use it as you age or succumb to carious disease conditions.

OUR SCIENCE

The human microbiota is the aggregate of microorganisms that resides on the surface and in deep layers of skin, in the saliva and oral mucosa, in the conjunctiva, and in the gastrointestinal tracts and the human microbiome refer to their genomes. The microbiome is reckoned to have around 3 million functional genes compared to human beings 23,000 and the far larger genome of the microbiome has correspondingly greater capabilities in modulating human health and well-being. Microbiome’s health and diversity is a growing theme in medical research for treating autoimmune, infectious, and metabolic diseases.

Biom Pharma | Biom Probiotics Sarasota | Human Microflora Probiotics | Human Microbiome | Microbial Flora | Probiotics Align | Human Microbiota

Microbiome & Health

Everyone’s got a personal collection of microbiota. You could think of yours as your unique internal pet—at up to 3 percent of your body mass requiring nurturing and feeding. In turn, your microbiota provides essential services: extracting energy from food, absorbing and generating vitamins and amino acids and forming barriers against infective invaders. New studies are showing your microbiota might also fight diabetes, obesity and cancer; stimulate your immune system; break down toxins; and boost your overall health.

The gut microbiota has a crucial role in metabolic health, but researchers are only just determining the mechanisms underpinning this effect. Studies have found that specific class of bacteria that degrades mucin in the gut lining and can have beneficial effects on metabolic disorders, has a key role in systemic glucose metabolism. These classes of bacteria modulate glucose metabolism by altering gene expression of certain key biomolecules in ileum.

Everyone’s microbiome appears to be unique and is readily modified by diet, its multiple microorganisms seem to have overlapping roles and applied microbiome interventions could revolutionize the way we think about gut bacteria in relation to weight loss, immunity, disease and the creation of essential nutrients.

Changes in microbiome composition and diversity are associated with the development of metabolic diseases and microbiome is considered as the next big platform for diagnostic and drug discovery for treating autoimmune, metabolic and infectious diseases. There are many benefits in microbiome-based approach in controlling or treating metabolic diseases unlike human genome sequence-based interventions. Further, emerging scientific information shows the importance of microbiome in determining your healthy life-span.

We at Biom Pharmaceuticals realize the enormous importance of human commensal microbiota. Our research and product development efforts are targeted towards harnessing the potential of microbiome for future personalized medicine and preventative care.